128 related articles for article (PubMed ID: 21856005)
21. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.
Reddy GP; Barrack ER; Dou QP; Menon M; Pelley R; Sarkar FH; Sheng S
J Cell Biochem; 2006 Aug; 98(6):1408-23. PubMed ID: 16619263
[TBL] [Abstract][Full Text] [Related]
22. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer.
Chen Z; Fan Z; McNeal JE; Nolley R; Caldwell MC; Mahadevappa M; Zhang Z; Warrington JA; Stamey TA
J Urol; 2003 Apr; 169(4):1316-9. PubMed ID: 12629351
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
[TBL] [Abstract][Full Text] [Related]
24. RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells.
Xu Y; Fang F; Sun Y; St Clair DK; St Clair WH
Mol Cancer Ther; 2010 Apr; 9(4):803-12. PubMed ID: 20371728
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
26. The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis.
Soysa NS; Alles N; Weih D; Lovas A; Mian AH; Shimokawa H; Yasuda H; Weih F; Jimi E; Ohya K; Aoki K
J Bone Miner Res; 2010 Apr; 25(4):809-18. PubMed ID: 19839765
[TBL] [Abstract][Full Text] [Related]
27. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
Kim S; Han J; Kim J; Park C
Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
[TBL] [Abstract][Full Text] [Related]
30. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
31. Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2.
Wang X; Belguise K; Kersual N; Kirsch KH; Mineva ND; Galtier F; Chalbos D; Sonenshein GE
Nat Cell Biol; 2007 Apr; 9(4):470-8. PubMed ID: 17369819
[TBL] [Abstract][Full Text] [Related]
32. RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity.
Xu Y; Josson S; Fang F; Oberley TD; St Clair DK; Wan XS; Sun Y; Bakthavatchalu V; Muthuswamy A; St Clair WH
Cancer Res; 2009 Apr; 69(8):3267-71. PubMed ID: 19351823
[TBL] [Abstract][Full Text] [Related]
33. Metallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells.
Juang HH; Chung LC; Sung HC; Feng TH; Lee YH; Chang PL; Tsui KH
Prostate; 2013 Oct; 73(14):1495-506. PubMed ID: 23794209
[TBL] [Abstract][Full Text] [Related]
34. MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells.
Duan H; Zhang HJ; Yang JQ; Oberley LW; Futscher BW; Domann FE
Antioxid Redox Signal; 2003 Oct; 5(5):677-88. PubMed ID: 14580325
[TBL] [Abstract][Full Text] [Related]
35. RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.
Xu J; Zhou P; Wang W; Sun A; Guo F
J Mol Med (Berl); 2014 Jan; 92(1):77-92. PubMed ID: 24042463
[TBL] [Abstract][Full Text] [Related]
36. Blockage of RelB expression by gene silencing enhances the radiosensitivity of androgen‑independent prostate cancer cells.
Zhu HC; Qiu T; Dan C; Liu XH; Hu CH
Mol Med Rep; 2015 Feb; 11(2):1167-73. PubMed ID: 25370388
[TBL] [Abstract][Full Text] [Related]
37. RelB/NF-κB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis.
Ge QL; Liu SH; Ai ZH; Tao MF; Ma L; Wen SY; Dai M; Liu F; Liu HS; Jiang RZ; Xue ZW; Jiang YH; Sun XH; Hu YM; Zhao YX; Chen X; Tao Y; Zhu XL; Ding WJ; Yang BQ; Liu DD; Zhang XR; Teng YC
Cell Death Dis; 2016 Oct; 7(10):e2402. PubMed ID: 27711077
[TBL] [Abstract][Full Text] [Related]
38. Gum mastic increases maspin expression in prostate cancer cells.
He ML; Chen WW; Zhang PJ; Jiang AL; Fan W; Yuan HQ; Liu WW; Zhang JY
Acta Pharmacol Sin; 2007 Apr; 28(4):567-72. PubMed ID: 17376297
[TBL] [Abstract][Full Text] [Related]
39. Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3.
Tao Y; Liu Z; Hou Y; Wang S; Liu S; Jiang Y; Tan D; Ge Q; Li C; Hu Y; Liu Z; Chen X; Wang Q; Wang M; Zhang X
Oncogene; 2018 Nov; 37(44):5887-5900. PubMed ID: 29973688
[TBL] [Abstract][Full Text] [Related]
40. Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.
Kiebala M; Polesskaya O; Yao Z; Perry SW; Maggirwar SB
PLoS One; 2010 Jul; 5(7):e11875. PubMed ID: 20686703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
